Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avid Bioservices Inc

CDMO
Current price
5 USD -0.065 USD (-1.28%)
Last closed 5.09 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 346 489 792 USD
Yield for 12 month -67.54 %
Week
Month
Year
CDMO
21.11.2021 - 28.11.2021

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Address: 2642 Michelle Drive, Tustin, CA, United States, 92780

Analytics

WallStreet Target Price

18.5 USD

P/E ratio

Dividend Yield

1.33 %

Current Year

+149 266 000 USD

Last Year

+119 597 000 USD

Current Quarter

+37 726 000 USD

Last Quarter

+39 799 000 USD

Current Year

+31 480 000 USD

Last Year

+36 648 000 USD

Current Quarter

+4 100 000 USD

Last Quarter

+8 391 000 USD

Key Figures CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 7 072 000 USD
Operating Margin TTM -5.73 %
PE Ratio
Return On Assets TTM -0.17 %
PEG Ratio
Return On Equity TTM -1.68 %
Wall Street Target Price 18.5 USD
Revenue TTM 150 300 000 USD
Book Value 3.02 USD
Revenue Per Share TTM 2.41 USD
Dividend Share
Quarterly Revenue Growth YOY 2.8 %
Dividend Yield 1.33 %
Gross Profit TTM 31 480 000 USD
Earnings Share -0.05 USD
Diluted Eps TTM -0.05 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -79.7 %
Profit Margin -2.06 %

Dividend Analytics CDMO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

12241 %

Dividend History CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 1.33 %
Last Split Factor 1:7
Payout Ratio
Last Split Date 10.07.2017
Dividend Date 10.07.2017

Stock Valuation CDMO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 81.3008
Enterprise Value Revenue 7.4951
Price Sales TTM 6.3803
Enterprise Value EBITDA 98.5317
Price Book MRQ 4.9759

Financials CDMO

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CDMO

For 52 weeks

4.91 USD 21.05 USD
50 Day MA 7.54 USD
Shares Short Prior Month 5 044 952
200 Day MA 13.45 USD
Short Ratio 8.62
Shares Short 5 391 727
Short Percent 10.2 %